Aspirin For Primary Prevention of MI Is Topic For Advisory Panel Meeting
FDA's Cardiovascular & Renal Drugs Advisory Committee will discuss whether aspirin should be recommended for primary prevention of myocardial infarction at a Dec. 8 meeting
FDA's Cardiovascular & Renal Drugs Advisory Committee will discuss whether aspirin should be recommended for primary prevention of myocardial infarction at a Dec. 8 meeting